<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Updated American Society of Clinical Oncology (ASCO) guideline on appropriate dosing for systemic anticancer therapy in obese adults with cancer</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Updated American Society of Clinical Oncology (ASCO) guideline on appropriate dosing for systemic anticancer therapy in obese adults with cancer</h1>
<div class="graphic"><div class="figure"><div class="ttl">Updated American Society of Clinical Oncology (ASCO) guideline on appropriate dosing for systemic anticancer therapy in obese adults with cancer</div><div class="cntnt"><table cellspacing="0"><tbody> <tr> <td class="subtitle1_single">Guideline question</td> </tr> <tr> <td class="indent1"> <ul> <li>How should antineoplastic doses be determined in obese adults?</li> </ul> </td> </tr> <tr> <td class="subtitle1_single">Target population</td> </tr> <tr> <td class="indent1"> <ul> <li>Obese adults who will receive systemic antineoplastic therapies (chemotherapy, immunotherapy, or targeted therapy).</li> </ul> </td> </tr> <tr> <td class="subtitle1_single">Target audience</td> </tr> <tr> <td class="indent1"> <ul> <li>Medical oncologists, oncology nurses, nurse practitioners, physician assistants, oncology pharmacists, and patients with cancer.</li> </ul> </td> </tr> <tr> <td class="subtitle1_single">Methods</td> </tr> <tr> <td class="indent1"> <ul> <li>An Expert Panel was convened to develop updated clinical practice guideline recommendations based on a systematic review of the medical literature.</li> </ul> </td> </tr> <tr> <td class="subtitle1_single">Recommendations</td> </tr> <tr> <td class="indent1"> <ul> <li>Full weight-based dosing of cytotoxic chemotherapy should be offered regardless of obesity status (type: evidence-based; evidence quality: low; strength of recommendation: moderate).</li> <li>The Panel recommends limiting fixed dosing of chemotherapy to select cytotoxic agents (eg, bleomycin). Although fixed dosing of other cytotoxic chemotherapeutic agents has been used in clinical trials, evidence remains limited that fixed-dosing strategies are equivalent to weight- or body surface area (BSA)-based dosing in terms of toxicity and efficacy (type: evidence-based; evidence quality: low; strength of recommendation: moderate).</li> <li>US Food and Drug Administration–approved prescribing information for checkpoint inhibitors should be used in all patients, regardless of obesity status (type: evidence-based; evidence quality: low; strength of recommendation: moderate).</li> <li>US Food and Drug Administration–approved prescribing information for targeted therapies should be used in all patients, regardless of obesity status (type: evidence-based; evidence quality: low; strength of recommendation: moderate).</li> <li>If an obese patient experiences high-grade toxicity from systemic antineoplastic therapy, clinicians should follow the same guidelines for dose reduction for all patients, regardless of obesity status (type: informal consensus; evidence quality: insufficient; strength of recommendation: weak).</li> <li>The Panel recommends that BSA be calculated using any of the standard formulae. There is no evidence to support one formula for calculating BSA over another (type: evidence-based; evidence quality: low; strength of recommendation: moderate).</li> </ul> </td> </tr> <tr> <td class="subtitle1_single">Additional resources</td> </tr> <tr> <td class="indent1"> <ul> <li>More information, including a supplement with additional evidence tables, slide sets, and clinical tools and resources, is available at <a href="http://www.asco.org/supportive-care-guidelines" target="_blank">www.asco.org/supportive-care-guidelines</a>. The Methodology Manual (available at <a href="http://www.asco.org/guideline-methodology" target="_blank">www.asco.org/guideline-methodology</a>) provides additional information about the methods used to develop this guideline. Patient information is available at <a href="http://www.cancer.net" target="_blank">www.cancer.net</a>.</li> </ul> </td> </tr> <tr> <td class="subtitle1_single">ASCO believes that cancer clinical trials are vital to inform medical decisions and improve cancer care, and that all patients should have the opportunity to participate.</td> </tr> </tbody></table></div><div class="graphic_lgnd">The full guideline with methodology, comprehensive discussions of the literature, full reference list, data supplements, evidence tables, and clinical tool and resources can be found at www.asco.org/guidelines/wbd. Patient information is available at www.cancer.net.</div><div class="graphic_reference">From: Griggs JJ, Bohlke K, Balaban EP. Appropriate systemic therapy dosing for obese adult patients with cancer: ASCO guideline update. J Clin Oncol 2021; 39:2037. DOI: <a href="https://ascopubs.org/doi/10.1200/JCO.21.00471?url_ver=Z39.88-2003&amp;rfr_id=ori:rid:crossref.org&amp;rfr_dat=cr_pub%20%200pubmed" target="_blank">10.1200/JCO.21.00471</a>. Copyright © 2021 American Society of Clinical Oncology. Reproduced with permission from Wolters Kluwer Health. Unauthorized reproduction of this material is prohibited.</div><div id="graphicVersion">Graphic 96680 Version 2.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
